Latest News & Updates

Breaking News

  • 11 hours ago

  • Simantini Singh Deo

FDA Finalizes Digital Health Technology Guidance Reshaping Remote Data Acquisition in Clinical Trials
Breaking News
FDA Refreshes IND Safety Reporting Guidance Under 21 CFR 312.32 for IND Sponsors

Simantini Singh Deo

Other trending news you may like to read

FDA Finalizes Digital Health Technology Guidance Reshaping Remote Data Acquisition in Clinical Trials

FDA's final DHT guidance sets binding expectations for remote data acquisition in clinical trials, affecting protocol design and submission strategy.

Simantini Singh Deo

Pharma Now

FDA Refreshes IND Safety Reporting Guidance Under 21 CFR 312.32 for IND Sponsors

FDA updates its IND safety reporting resource, clarifying 21 CFR 312.32 thresholds, timelines, and submission requirements for active IND sponsors.

Simantini Singh Deo

Pharma Now

FDA Launches Guidance Snapshot Pilot Covering Master Protocols and Bayesian Methodology Drafts

FDA's Guidance Snapshot Pilot debuts with Master Protocols and Bayesian Methodology drafts, offering regulatory teams structured access to cross-cutting clinical trial guidance.

Simantini Singh Deo

Pharma Now

Roche Gains FDA Priority Review for Colon Cancer Drug with October 2026 Decision Date

FDA grants Roche Priority Review for a colon cancer drug, setting a 9 October 2026 decision date after trial data showed 50% recurrence reduction.

Vaibhavi M.

Pharma Now